GSK's ViiV launches first campaign for new HIV med Dovato with real patient ambassadors

GlaxoSmithKline’s first campaign for new two-in-one HIV pill Dovato centers on real patients who want to be seen for who they are, not as a diagnosis. “So much goes into who I am,” says one patient who stars in the drug's first TV ad.